Detalhe da pesquisa
1.
Role of ZNF224 in cell growth and chemoresistance of chronic lymphocitic leukemia.
Hum Mol Genet
; 26(2): 344-353, 2017 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28040726
2.
A multiparametric niche-like drug screening platform in acute myeloid leukemia.
Blood Cancer J
; 12(6): 95, 2022 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35750691
3.
Cystine uptake inhibition potentiates front-line therapies in acute myeloid leukemia.
Leukemia
; 36(6): 1585-1595, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35474100
4.
P2RY2-AKT activation is a therapeutically actionable consequence of XPO1 inhibition in acute myeloid leukemia.
Nat Cancer
; 3(7): 837-851, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668193
5.
Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor.
Sci Transl Med
; 13(587)2021 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33790022
6.
The Folate Cycle Enzyme MTHFR Is a Critical Regulator of Cell Response to MYC-Targeting Therapies.
Cancer Discov
; 10(12): 1894-1911, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32826232
7.
ZNF224 is a transcriptional repressor of AXL in chronic myeloid leukemia cells.
Biochimie
; 154: 127-131, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30176265
8.
Role of ZNF224 in c-Myc repression and imatinib responsiveness in chronic myeloid leukemia.
Oncotarget
; 9(3): 3417-3431, 2018 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29423056
9.
The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein.
Leuk Res
; 40: 60-7, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26563595
10.
WT1-mediated repression of the proapoptotic transcription factor ZNF224 is triggered by the BCR-ABL oncogene.
Oncotarget
; 6(29): 28223-37, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26320177